WO2003016476A3 - Gene expression profiles in glomerular diseases - Google Patents
Gene expression profiles in glomerular diseases Download PDFInfo
- Publication number
- WO2003016476A3 WO2003016476A3 PCT/US2002/025766 US0225766W WO03016476A3 WO 2003016476 A3 WO2003016476 A3 WO 2003016476A3 US 0225766 W US0225766 W US 0225766W WO 03016476 A3 WO03016476 A3 WO 03016476A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- gene expression
- glomerular diseases
- expression profiles
- pbl
- glomerular
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002324701A AU2002324701A1 (en) | 2001-08-14 | 2002-08-14 | Gene expression profiles in glomerular diseases |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31183701P | 2001-08-14 | 2001-08-14 | |
US60/311,837 | 2001-08-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003016476A2 WO2003016476A2 (en) | 2003-02-27 |
WO2003016476A3 true WO2003016476A3 (en) | 2003-05-08 |
Family
ID=23208719
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/025766 WO2003016476A2 (en) | 2001-08-14 | 2002-08-14 | Gene expression profiles in glomerular diseases |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002324701A1 (en) |
WO (1) | WO2003016476A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7253148B2 (en) * | 2003-03-07 | 2007-08-07 | The Research Foundation Of State University Of New York | Human gene with immunoregulatory and anti-proliferative properties |
US20050186577A1 (en) | 2004-02-20 | 2005-08-25 | Yixin Wang | Breast cancer prognostics |
US7608395B2 (en) * | 2005-09-15 | 2009-10-27 | Baylor Research Institute | Systemic lupus erythematosus diagnostic assay |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6114123A (en) * | 1999-06-14 | 2000-09-05 | Incyte Pharmaceuticals, Inc. | Lipocalin family protein |
US6268342B1 (en) * | 1996-08-30 | 2001-07-31 | Biomeasure Incorporated | Method of inhibiting fibrosis with a somatostatin agonist |
-
2002
- 2002-08-14 AU AU2002324701A patent/AU2002324701A1/en not_active Abandoned
- 2002-08-14 WO PCT/US2002/025766 patent/WO2003016476A2/en not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6268342B1 (en) * | 1996-08-30 | 2001-07-31 | Biomeasure Incorporated | Method of inhibiting fibrosis with a somatostatin agonist |
US6114123A (en) * | 1999-06-14 | 2000-09-05 | Incyte Pharmaceuticals, Inc. | Lipocalin family protein |
Also Published As
Publication number | Publication date |
---|---|
WO2003016476A2 (en) | 2003-02-27 |
AU2002324701A1 (en) | 2003-03-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006050475A3 (en) | Identification of dysregulated genes in patients with neurological diseases | |
WO2005039382A3 (en) | Prediction of likelihood of cancer recurrence | |
WO2005034940A8 (en) | Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological, inflammatory, neuronal and other diseases | |
PL1835924T3 (en) | Treatment of parkinson's disease and related disorders using postpartum derived cells | |
WO2004028339A3 (en) | Treatment of patients with multiple sclerosis based on gene expression changes in central nervous system tissues | |
AU2003228936A1 (en) | Identification of dysregulated genes in patients with multiple sclerosis | |
WO2008057457A3 (en) | Antagonists of pcsk9 | |
WO2002074992A3 (en) | Phosphodiesterase 4d genes related to human stroke | |
HUP0500054A2 (en) | Method for identification of tumor targeting enzymes | |
WO2008008569A3 (en) | Prelamin a pre peptide as a universal stem cell differentiation signal | |
AU2003249645A1 (en) | METHODS FOR THE IDENTIFICATION OF IKKAlpha FUNCTION AND OTHER GENES USEFUL FOR TREATMENT OF INFLAMMATORY DISEASES | |
WO2004093788A3 (en) | Desmoglein 4 is a novel gene involved in hair growth | |
WO2002012440A3 (en) | Identifying drugs for and diagnosis of benign prostatic hyperplasia using gene expression profiles | |
ATA14332001A (en) | ROLLING MILL FOR THE PRODUCTION OF ROLLING STRIP | |
WO2003016476A3 (en) | Gene expression profiles in glomerular diseases | |
WO2007017146A3 (en) | Use of collismycin and derivatives thereof as oxidative stress inhibitors | |
WO2004022756A3 (en) | Protein kinases | |
WO2005022146A3 (en) | Diagnostics and therapeutics for diseases associated with kallikrein 13 (klk13) | |
GB0300718D0 (en) | Proteins | |
WO2006043060A3 (en) | Mam domain containing protein | |
NO20053575D0 (en) | Metal protease proteins | |
WO2005022164A3 (en) | Diagnostics and therapeutics for diseases associated with kallikrein 8 (klk8) | |
WO2003026566A3 (en) | Atlastin | |
WO2003050303A3 (en) | Biallelic markers of d-amino acid oxidase and uses thereof | |
WO2005052180A3 (en) | Ntrk1 genetic markers associated with progression of alzheimer’s disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VC VN YU ZA ZM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |